P Emery Selected Research

Rheumatoid Arthritis

06/2008	Improvement in patient-reported outcomes in a rituximab trial in patients with severe rheumatoid arthritis refractory to anti-tumor necrosis factor therapy.
06/2008	Rituximab use in everyday clinical practice as a first-line biologic therapy for the treatment of DMARD-resistant rheumatoid arthritis.
04/2008	A pilot study of combination anti-cytokine and anti-lymphocyte biological therapy in rheumatoid arthritis.
01/2008	Atacicept in patients with rheumatoid arthritis: Results of a multicenter, phase ib, double-blind, placebo-controlled, dose-escalating, single- and repeated-dose study.
09/2007	Quality of life in patients with rheumatoid arthritis: does abatacept make a difference?
07/2007	Long-term infliximab treatment in rheumatoid arthritis: subsequent outcome of initial responders.
02/2007	Abatacept improves both the physical and mental health of patients with rheumatoid arthritis who have inadequate response to methotrexate treatment.
02/2007	Consensus statement on the use of rituximab in patients with rheumatoid arthritis.
12/2006	Sustained benefit in rheumatoid arthritis following one course of rituximab: improvements in physical function over 2 years.
11/2006	Can remission be maintained with or without further drug therapy in rheumatoid arthritis?
09/2006	Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate.
04/2006	Anti-CCP antibodies measured at disease onset help identify seronegative rheumatoid arthritis and predict radiological and functional outcome.
02/2005	Debridement of plantar callosities in rheumatoid arthritis: a randomized controlled trial.
10/2004	True infliximab resistance in rheumatoid arthritis: a role for lymphotoxin alpha?
05/2004	Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed.
02/2004	Infliximab in active early rheumatoid arthritis.
12/2003	Efficacy and safety of the fully human anti-tumour necrosis factor alpha monoclonal antibody adalimumab (D2E7) in DMARD refractory patients with rheumatoid arthritis: a 12 week, phase II study.
06/2003	The efficacy and safety of leflunomide in patients with active rheumatoid arthritis: a five-year followup study.
12/2001	Serum soluble interleukin 2 receptor levels and radiological progression in early rheumatoid arthritis.
11/2001	A human glucocorticoid receptor gene variant that increases the stability of the glucocorticoid receptor beta-isoform mRNA is associated with rheumatoid arthritis.
10/2001	Autologous stem cell transplantation for rheumatoid arthritis--interim report of 6 patients.
03/2001	Infliximab: a new treatment for rheumatoid arthritis.
03/2001	Detection of Mycobacterium tuberculosis group organisms in human and mouse joint tissue by reverse transcriptase PCR: prevalence in diseased synovial tissue suggests lack of specific association with rheumatoid arthritis.
02/2001	Minocycline induced autoimmune disease in rheumatoid arthritis: a missed diagnosis?
02/2001	Rheumatoid arthritis synovial T cells regulate transcription of several genes associated with antigen-induced anergy.
01/2001	Leflunomide: a novel DMARD for the treatment of rheumatoid arthritis.
11/2000	Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.
08/2000	Modulation of inflammation and metalloproteinase expression in synovial tissue by leflunomide and methotrexate in patients with active rheumatoid arthritis. Findings in a prospective, randomized, double-blind, parallel-design clinical trial in thirty-nine patients at two centers.
08/2000	Racial origin and its effect on disease expression and HLA-DRB1 types in patients with rheumatoid arthritis: a matched cross-sectional study.
07/2000	Leflunomide, a new disease-modifying anti-rheumatic drug and the never ending rheumatoid arthritis story.
06/2000	Efficacy and safety of leflunomide in active rheumatoid arthritis.
05/2000	Leflunomide: a new DMARD for rheumatoid arthritis.
02/2000	Microemulsion formulation of cyclosporin (Sandimmun Neoral) vs Sandimmun: comparative safety, tolerability and efficacy in severe active rheumatoid arthritis. On behalf of the OLR 302 Study Group.

Articles by Research Topic

Disease

33	Rheumatoid Arthritis 06/2008 - 02/2000
4	Ankylosing Spondylitis 02/2008 - 09/2004
3	Inflammation 12/2007 - 08/2000
3	Arthritis (Polyarthritis) 01/2007 - 09/2001
3	Necrosis 11/2005 - 12/2003
2	Syndrome 04/2006 - 03/2005
2	Rheumatic Diseases (Rheumatism) 11/2005 - 11/2004
2	Psoriatic Arthritis 06/2005 - 05/2003
2	Systemic Scleroderma (Systemic Sclerosis) 08/2004 - 06/2001
2	Autoimmune Diseases (Autoimmune Disease) 02/2001 - 12/2000
1	Interstitial Lung Diseases (Interstitial Lung Disease) 04/2008
1	Gout 12/2007
1	Acne Vulgaris 05/2007
1	Callosities 02/2005
1	Lupus Nephritis 05/2004
1	Pain (Aches) 05/2003
1	Giant Cell Arteritis (Horton Disease) 04/2003
1	Colitis 01/2003
1	Spondylarthropathies 09/2001
1	Skin Diseases 06/2001
1	Polymyositis 06/2001

Drug/Important Bio-Agent (IBA)

6	infliximab (Remicade)FDA Link 07/2007 - 11/2000
6	Methotrexate (Mexate)FDA LinkGeneric 02/2007 - 08/2000
6	leflunomide (Arava)FDA LinkGeneric 06/2003 - 05/2000
5	rituximab (Mabthera)FDA Link 06/2008 - 12/2006
4	Antirheumatic Agents (DMARD)IBA 06/2008 - 05/2000
4	TNFR-Fc fusion protein (etanercept)FDA Link 12/2004 - 09/2001
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2008 - 11/2000
3	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 02/2008 - 09/2004
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 06/2005 - 02/2000
2	abatacept (BELATACEPT)FDA Link 09/2007 - 02/2007
2	Minocycline (Cyclops)FDA LinkGeneric 05/2007 - 02/2001
2	Interleukin-1 (Interleukin 1)IBA 11/2005 - 11/2004
2	adalimumab (Humira)FDA Link 05/2004 - 12/2003
1	TACI receptor-IgG Fc fragment fusion proteinIBA 01/2008
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 05/2007
1	Interleukin-6 (Interleukin 6)IBA 09/2006
1	tocilizumabIBA 09/2006
1	AntibodiesIBA 04/2006
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 04/2006
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 03/2005
1	Lymphotoxin-alpha (Lymphotoxin)IBA 10/2004
1	Azathioprine (Imuran)FDA LinkGeneric 05/2004
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2004
1	Methylprednisolone FDA LinkGeneric 05/2004
1	Prednisolone (Predate)FDA LinkGeneric 05/2004
1	Technetium Tc 99m ciprofloxacinIBA 10/2003
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 12/2001
1	glucocorticoid receptor betaIBA 11/2001
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 11/2001
1	Messenger RNA (mRNA)IBA 11/2001
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 09/2001
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 03/2001
1	AntigensIBA 02/2001
1	HLA-DRB1 antigen (HLA DRB1)IBA 08/2000

Therapy/Procedure

5	Stem Cell Transplantation 08/2004 - 12/2000
2	Biological Therapy 06/2008 - 04/2008
1	Therapeutics 01/2007
1	Drug Therapy (Chemotherapy) 11/2006
1	Debridement 02/2005